Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COCOA: GLP-1 and Glucagon Haemodynamic Effects
NCT03835013Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Feb 2019
- Primary completion
- Nov 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of exenatide and glucagon in type 2 diabetes mellitus (T2DM) and obesity, sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Feb 2019; status: completed.
02
Drugs
exenatideglucagon
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT03835013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03835013.